Evidence map›Paper›PMID 21800101›Full record

ReviewTransgenic research2012

The construction of transgenic and gene knockout/knockin mouse models of human disease.

Alfred Doyle, Michael P McGarry, Nancy A Lee, James J Lee

Abstract readReview
In one paragraph

Review in Transgenic research, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 88 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
88citing papers in PubMed, 1 pooled it
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

88 citing papers in PubMed, 1 synthesis or guideline pooled it, 200 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review

28 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Alfred DoyleDivision of Pulmonary Medicine, Department of Biochemistry and Molecular Biology, MCCRB; Cr2-206, Mayo Clinic Arizona, 13400 E. Shea Blvd., Scottsdale, AZ 85259, USA.
Michael P McGarry
Nancy A Lee
James J Lee
Mayo Clinic in Arizona · USWinnMed · US

Funding

EOSINOPHIL ACTIVITIES IN MURINE MODELS OF LUNG DISEASER01HL065228 · NHLBI · MAYO CLINIC COLL OF MED, MAYO CLINIC AZ · PI JACOBSEN, ELIZABETH A · 2000 to 2017
$6.7M
MOUSE MODELS OF EOSINOPHIL ASSOCIATED LUNG DYSFUNCTIONR01HL058723 · NHLBI · MAYO CLINIC COLL OF MED, MAYO CLINIC AZ · PI LEE, NANCY A. · 1998 to 2013
$4.2M
Mechanisms of Eosinophil Effector Functions in the LungK26RR019709 · NCRR · MAYO CLINIC ARIZONA · PI LEE, JAMES JOSEPH · 2005 to 2009
$578k
Mouse Models of Eosinophil-Associated Lung DysfunctionR56HL058723 · NHLBI · MAYO CLINIC ARIZONA · PI LEE, NANCY A. · 2008 to 2008
$400k
NCRR NIH HHS K26 RR019709NCRR NIH HHS K26-RR019709NHLBI NIH HHS HL058723NHLBI NIH HHS HL065228NHLBI NIH HHS R01 HL058723NHLBI NIH HHS R01 HL065228NHLBI NIH HHS R56 HL058723
6 · The paper itself

Abstract

The genetic and physiological similarities between mice and humans have focused considerable attention on rodents as potential models of human health and disease. Together with the wealth of resources, knowledge, and technologies surrounding the mouse as a model system, these similarities have propelled this species to the forefront of biomedical research. The advent of genomic manipulation has quickly led to the creation and use of genetically engineered mice as powerful tools for cutting edge studies of human disease research including the discovery, refinement, and utility of many currently available therapeutic regimes. In particular, the creation of genetically modified mice as models of human disease has remarkably changed our ability to understand the molecular mechanisms and cellular pathways underlying disease states. Moreover, the mouse models resulting from gene transfer technologies have been important components correlating an individual's gene expression profile to the development of disease pathologies. The objective of this review is to provide physician-scientists with an expansive historical and logistical overview of the creation of mouse models of human disease through gene transfer technologies. Our expectation is that this will facilitate on-going disease research studies and may initiate new areas of translational research leading to enhanced patient care.

Indexed as

Disease Models, AnimalGene Expression RegulationAnimalsChromosomes, MammalianGene Knock-In TechniquesGene Knockout TechniquesGene TargetingGenetic EngineeringGene Transfer TechniquesGenomeHumansMiceMice, KnockoutPancreatic NeoplasmsSequence Homology, Nucleic AcidSpecies Specificity

Identifiers

PMID21800101
PMCPMC3516403
OpenAlexW2062028934

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.